ResMed Inc. (RMD)

ResMed Inc. (RMD) scores 86 out of 100 on boothcheck's 11-model valuation framework. Verdict: Fair The estimated fair value is 215.63, representing a 3% premium to fair value. Quantitative score: 77/100. Qualitative score: 100/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full RMD analysis on boothcheck